Preparation and physicochemical characterization of sildenafil cocrystals
Open Access
- 1 October 2021
- journal article
- research article
- Published by Medknow in Journal of Advanced Pharmaceutical Technology & Research
- Vol. 12 (4) , 408-419
Abstract
Sildenafil is a specific inhibitor of the phosphodiesterase type 5 (PDE-5) enzyme that protects cyclic guanosine monophosphate from breakdown by PDE-5. It is a biopharmaceutical categorization system Class II medication with low bioavailability because it is almost insoluble in water. The objectives of this study were to prepare sildenafil cocrystals with co-former molecules including aspirin (acetylsalicylic acid [ASA]), fumaric acid (FMA), and benzoic acid (BZA) to improve the water solubility of sildenafil. The cocrystals were prepared by antisolvent addition (AA) and slow solvent evaporation (SE) methods. The stoichiometric ratios of sildenafil and co-former molecules were varied. The obtained crystals were characterized by stereomicroscope, Fourier transformed infrared spectroscopy (FT-IR), nuclear magnetic resonance (NMR), and powder X-ray diffraction (PXRD). The water solubility of sildenafil cocrystals was compared with sildenafil base. In the AA method, the crystals only form in sildenafil-ASA reaction. These crystals were not cocrystals between sildenafil and ASA because they were formed to new substances that were confirmed by single-crystal X-ray diffraction. In the SE method, the cocrystals were successfully prepared in the reaction of sildenafil with ASA, FMA, and BZA which use acetone or ethyl acetate as a solvent. The obtained crystals are irregular shapes and their FT-IR, NMR, and PXRD results exhibited the characteristics of sildenafil and its co-former. The stoichiometric ratios of sildenafil and co-formers after cocrystallization were different from an initial of crystallization. The sildenafil cocrystals with ASA, FMA, and BZA by SE method had higher water solubility than sildenafil base. The sildenafil-FMA cocrystals had the highest water solubility and increased up to five times when compared with sildenafil base.Keywords
This publication has 20 references indexed in Scilit:
- Why sildenafil and sildenafil citrate monohydrate crystals are not stable?Saudi Pharmaceutical Journal, 2015
- Salt and Cocrystals of Sildenafil with Dicarboxylic Acids: Solubility and Pharmacokinetic Advantage of the Glutarate SaltMolecular Pharmaceutics, 2013
- A sildenafil cocrystal based on acetylsalicylic acid exhibits an enhanced intrinsic dissolution rateCrystEngComm, 2013
- Sildenafil citrate monohydrate–cyclodextrin nanosuspension complexes for use in metered-dose inhalersInternational Journal of Pharmaceutics, 2013
- Pharmaceutical cocrystals: An overviewInternational Journal of Pharmaceutics, 2011
- Comparison of the solubility and pharmacokinetics of sildenafil saltsArchives of Pharmacal Research, 2011
- Growth of (CH3)2NH2CuCl3 single crystals using evaporation method with different temperatures and solventsJournal of Crystal Growth, 2010
- Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification SystemBritish Journal of Clinical Pharmacology, 2010
- Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertensionDrug Design, Development and Therapy, 2010
- Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculationUrology, 2006